Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)

Ann Oncol. 1999 Feb;10(2):243-4. doi: 10.1023/a:1008308115848.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Small Cell / drug therapy*
  • Cisplatin / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Health Care Costs
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Ifosfamide / administration & dosage
  • Lung Neoplasms / drug therapy*
  • Middle Aged

Substances

  • Etoposide
  • Doxorubicin
  • Cisplatin
  • Ifosfamide

Supplementary concepts

  • EAP protocol
  • ICE protocol 1